Clinical trial
Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
NCT00285857
Study timeline
Study start (unknown)2005-11-01Date precision: month
Registry last updated2017-03-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
LovastatinDRUG · verified · RxNorm: lovastatin
Sponsors & collaborators
Stanford Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00285857 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.